Indications
Therapeutic Asset Ratings
6,305 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ctx131
Nonpapillary Renal Cell Carcinoma
CRISPR Therapeutics AG
P1/2
CC
(46)
ctx131
Pancreatic Adenocarcinoma
CRISPR Therapeutics AG
P1/2
CC
(46)
Cyclophosphamide
Cognitive Disorder
University of Washington
P1/2
CC
(46)
Cypep-1
Breast Cancer
Cytovation AS
P1/2
CC
(46)
Cypep-1
Melanoma
Cytovation AS
P1/2
CC
(46)
Defactinib
Glioblastoma
Institute of Cancer Research, United Kingdom
P1/2
CC
(46)
Dexasone
Triple-Negative Breast Carcinoma
Andrew Hantel, MD
P1/2
CC
(46)
Disodium 4-((Tert-Butylimino)Methyl)Benzene-1,3-Disulfonate N-Oxide
Glioblastoma
Oblato, Inc.
P1/2
CC
(46)
Docetaxel
Biliary Tract Cancer
Cantargia AB
P1/2
CC
(46)
Docetaxel
Colorectal Adenocarcinoma
Akeso
P1/2
CC
(46)
Dpa-714
Parkinson Disease
University of Alabama at Birmingham
P1/2
CC
(46)
dzd6008
Non-Small Cell Lung Carcinoma
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
P1/2
CC
(46)
e-602
Urinary Bladder Carcinoma
Palleon Pharmaceuticals, Inc.
P1/2
CC
(46)
e-602
Head And Neck Cancer
Palleon Pharmaceuticals, Inc.
P1/2
CC
(46)
Elironrasib
Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.
P1/2
CC
(46)
Fludarabine
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P1/2
CC
(46)
Fludarabine
Liver Cancer
Beijing Biotech
P1/2
CC
(46)
Fractalkine Receptor Antagonist Kand567
Ovarian Carcinoma
Novakand Pharma AB
P1/2
CC
(46)
Fulvestrant
Cervical Cancer
Terremoto Biosciences Inc.
P1/2
CC
(46)
Fulvestrant
Head And Neck Squamous Cell Carcinoma
Terremoto Biosciences Inc.
P1/2
CC
(46)
Fulvestrant
Metastatic Prostate Carcinoma
Novartis Pharmaceuticals
P1/2
CC
(46)
Gedatolisib
Castration-Resistant Prostate Carcinoma
Celcuity Inc
P1/2
CC
(46)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Head And Neck Cancer
Kineta Inc.
P1/2
CC
(46)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Kidney Cancer
Kineta Inc.
P1/2
CC
(46)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Sarcoma
Kineta Inc.
P1/2
CC
(46)
Showing 2776 to 2800 of 6,305 assets
Previous
Page 112 of 253
Next